Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19

Area of Science:

• Immunology
• Cardiology
• Neurology
• Nephrology
• Virology

Background:

• COVID-19, caused by SARS-CoV-2, presents as a multi-system syndrome, not just respiratory illness.
• SARS-CoV-2 infection is associated with increased morbidity and mortality, particularly in patients with cardiometabolic conditions.
• A hyperinflammatory syndrome, or cytokine release syndrome, is observed in severe COVID-19 cases, contributing to multiorgan damage.

Purpose of the Study:

• To investigate the role of autonomic dysfunction in the cytokine release syndrome and multiorgan damage in COVID-19.
• To explore the cholinergic anti-inflammatory pathway as a potential therapeutic target for COVID-19.

Main Methods:

• Review of emerging evidence on SARS-CoV-2 interactions with multiple organ systems.
• Analysis of the potential contribution of autonomic tone dysfunction to COVID-19 pathogenesis.
• Hypothesizing therapeutic strategies targeting the cholinergic anti-inflammatory pathway.

Main Results:

• SARS-CoV-2 impacts cardiovascular, nervous, renal, and immune systems, leading to myocardial injury and dysfunction.
• Autonomic dysfunction may contribute to the hyperinflammatory cytokine release syndrome in COVID-19.
• This dysfunction is linked to multiorgan damage observed in severe cases.

Conclusions:

• Autonomic dysfunction is a potential contributor to severe COVID-19 outcomes, including cytokine release syndrome and multiorgan damage.
• Targeting the cholinergic anti-inflammatory pathway presents a promising therapeutic avenue for managing COVID-19.